Drugs for Endometrial (Uterine) Cancer

Table. Drugs Prescribed for Endometrial (Uterine) Cancer

• Drug name (generic name)
• Drug company
• Indications
• Patient support services

Drug name (generic name)
• Jemperli (dostarlimab-gxly) Injection
Drug company
• GSK Oncology
Indication
• Treatment of adults with recurrent or advanced endometrial cancer and dMMR, as determined by an FDA-approved test, that has progressed during or after treatment with a platinum-containing regimen
Patient support services
• Together with GSK Oncology Commercial Co-pay Program
  844-447-5662
  
  Jemperli Patient Assistance Program
  844-447-5662

Drug name (generic name)
• Keytruda (pembrolizumab)
Drug company
• Merck
Indication
• Treatment, in combination with Lenvima, of patients with advanced endometrial carcinoma without MSI-H abnormality or dMMR, whose disease progressed after systemic therapy and who are not candidates for curative surgery or radiation
  
  As a single agent, for patients with advanced endometrial carcinoma that is MSI-H or dMMR whose disease progressed after systemic therapy and who are not candidates for curative surgery or radiation
Patient support services
• Merck Co-pay Assistance Program
  855-257-3932
  
  Merck Patient Assistance Program
  855-257-3932

Drug name (generic name)
• Lenvima (lenvatinib) Capsules
Drug company
• Eisai
Indication
• Treatment, in combination with Keytruda, of patients with advanced endometrial carcinoma without MSI-H abnormality or dMMR, whose disease progressed after previous systemic therapy and who are not candidates for curative surgery or radiation
Patient support services
• Lenvima $0 Co-Pay Program
  866-613-4724
  
  Lenvima Patient Assistance Program
  866-613-4724